The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): Stryker Corporation (SYK) pays a $3.48 annual dividend ($0.88 quarterly), yielding 1.15% at $303.13/share. Next ex-dividend date 2026-09-30. 16 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.15%
Annual Dividend: $3.48 per share
Payout Ratio: 35.3%
Ex-Dividend Date: 2026-09-30
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 36
Stryker Corporation dividend investors are buying into one of medical technology's most recognized names, a company spanning joint replacement implants, surgical navigation systems, and neurotechnology devices sold across roughly 75 countries. SYK currently yields 1.15%, with a trailing annual dividend rate of $3.48 per share paid quarterly. The next ex-dividend date is September 30, 2026. A beta of 0.768 points to below-market price swings, which suits investors who want dividend growth without the volatility of higher-beta healthcare names.
Stryker Corporation pays out 35.3% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial room to sustain and grow the dividend, backed by demand across two broad business segments: implants for hip, knee, and spinal procedures, and a wide array of surgical and neurotechnology equipment sold to hospitals and healthcare institutions worldwide. Stryker Corporation dividend safety faces its most realistic pressure from acquisition-driven balance sheet changes, given the company's global scale and product breadth, though the current payout ratio alone does not signal near-term stress.
Stryker Corporation dividend history shows a CAGR of 11.4% per year from 2011 to 2025. The per-share annual dividend grew from $0.7525 to $3.40 over that window (2026 data is partial and excluded from the CAGR calculation). The smallest annual increase in the window was 4.9% in 2025, a step down from the double-digit pace seen in earlier years. That deceleration is worth watching, but 16 consecutive years of increases still reflects a long, unbroken run of dividend growth.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +6.2% | $2.83 (2022) | $3.40 (2025) |
| 5-Year | +7.6% | $2.35 (2020) | $3.40 (2025) |
| 10-Year | +9.2% | $1.42 (2015) | $3.40 (2025) |
SYK fits growth-and-income investors who want a rising dividend stream from a large medical technology business rather than a high current payout. The yield is low (below 2%), sitting at 1.15% today versus a 5-year average of 1.0%, so the current yield is modestly above its own historical norm. What investors get is an 11.4% annualized dividend growth rate over 14 years and a conservative 35.3% payout ratio that leaves room for further increases. The trade-off is straightforward: current income is thin, and anyone prioritizing yield today will find SYK stock underwhelming on that metric alone.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-30 | $0.8800 |
| 2026-06-30 | $0.8800 |
| 2026-03-31 | $0.8800 |
| 2025-12-31 | $0.8800 |
| 2025-09-30 | $0.8400 |
| 2025-06-30 | $0.8400 |
| 2025-03-31 | $0.8400 |
| 2024-12-31 | $0.8400 |
| 2024-09-30 | $0.8000 |
| 2024-06-28 | $0.8000 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.6400 |
| 2025 | $3.4000 |
| 2024 | $3.2400 |
| 2023 | $3.0500 |
| 2022 | $2.8350 |
Project income from SYK with the SYK dividend calculator or track your full portfolio with the dividend tracker.